Skip to main content

Table 2 Serum lipid profiles of study population by HAART status in Hawassa, Southern Ethiopia

From: Prevalence of dyslipidemia among HIV-infected patients using first-line highly active antiretroviral therapy in Southern Ethiopia: a cross-sectional comparative group study

Parameters

HAART group (n=113)

Pre-HAART group (n=113)

Total cholesterol, mean ± SD

199.6 (51.5)

155.4 (44) ***

 < 200mg/dl

64 (56.6%)

95 (84.1%)

 ≥ 200mg/dl

49 (43.4%)

18 (15.9%) ***

HDL-cholesterol, mean ± SD

43.2 (14.3)

33.3 (12.8 ) ***

 < 40mg/dl

49 (43.4%)

72 (63.7%) **

 ≥ 40mg/dl

64 (56.6%)

41 (36.3%)

LDL-cholesterol, mean ± SD

119.3 (43)

97.3 (36.2) ***

 < 130mg/dl

75 (66.4%)

96 (85%)

 ≥ 130mg/dl

38 (33.6%)

17 (15.0%) **

Triglycerides, mean ± SD

204 (143)

138 (76 ) ***

 < 150mg/dl

50 (44.2%)

78 (69%)

 ≥150mg/dl

63 (55.8%)

35 (31.0%) ***

TC/HDL-c ratio, mean ± SD

5.2 (2.4)

5.3 (2.6)

 < 5

62 (54.9%)

64 (56.6%)

 ≥ 5

51 (45.1%)

49 (43.4%)

  1. HAART, highly active antiretroviral therapy; TC, total cholesterol; HDL, high-density lipoprotein; LDL, low- density lipoprotein; SD, standard deviation;** p-value < 0.01; *** p-value <0.001.